Results

Total Results: 801 records

Showing results for "described".

61. Serological Screening for Genital Herpes: A Reaffirmation Evidence Update for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/XW6XUe2wRmkM-6Rrbn_462
    February 01, 2023 - Their sampling strategy was often not adequately described. … for the outcome of interest (i.e., sensitivity, specificity), screening test well described in terms … Fair: Mostly includes a relevant and adequately described study population for the outcome of interest … (i.e., sensitivity, specificity), screening test described although may include some ambiguity about … Were population selection criteria clearly described?

62. Physicians’ Roles in Preventing Dental Caries in Preschool Children: A Summary of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/xXX8ZeqpmqtMURtJSfub56
    April 01, 2004 - Assignment method Hamberg, 197127 Sweden, ~0.2 ppm 2–3 wk (705) 0.5 mg F&V drops V drops Not described … 1–4 mo (297)‡ 0–3 y: 0.5 mg F&V drops 3 + y: 1.0 mg F&V chews 0–3 y: V drops 3+ y: V chews Not described … ) 2 y: 0.25 mg F drops 3 + y: 0.5 F drops None Children grouped by school, school assignment not described … 22–26|| mo (140) E1: 0.25 mg F drops E2: 0.25 mg F chews None Random, method of randomization not described … The single available study described an ineffective intervention.

63. Screening for Suicide Risk - Recommendation and Rationale (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/pxMbTT69NULYZRaZ9xs7Du
    May 01, 2004 - for Suicide Risk: USPSTF Recommendations 3 Screening for Suicide Risk: USPSTF Recommendations described … Improvements were described in patients with a history of DSH who participated in problem-solving therapy

64. Evidence Summary: Vision in Children Ages 6 Months to 5 Years: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/vision-in-children-ages-6-months-to-5-years-screening
    September 05, 2017 - In addition, the method of randomization in the (self-described) RCT was inadequate (based on last digit … Thirty-four fair-quality studies (described in 38 articles) were included (eTables 6-17 in the Supplement … study that evaluated potential psychosocial effects was included, 87 and 16 studies of test accuracy described … Three trials (described in 4 articles) were included ( Table 4 ). 40 , 44 , 50 , 63 Overall, the trials … The previous review for the USPSTF described head-to-head trials that compared different patching regimens

65. Archived: Evidence Summary: Breast Cancer: Screening, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-screening-2002
    September 03, 2002 - Their methods were poorly described, which limits precision in critical appraisal. … As described below, we used a systematic approach to assess the flaws of the trials in each of these … all-cause mortality in control group suggest inadequate randomization Allocation concealment not described … Allocation concealment not described Allocation concealment not described Allocation concealment … not described; intervention women slightly older than controls    Relative risk for all-cause

66. Preventiontaskforce Data Api Wi (pdf file)
    www.uspreventiveservicestaskforce.org/files/preventiontaskforce_data_api_wi.pdf
    November 17, 2020 - patient characteristics, such as age, sex, selected behavioral risk factors, and recommendation grades as described

67. Procedure Manual Section 9. Engagement With the Public, Stakeholders, and Partners | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-9-engagement-public-stakeholders-and-partners
    July 09, 2017 - Different dissemination activities, described below, are conducted for researchers; clinicians; members

68. Final Research Plan: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    January 13, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Prevention of Acquisition of HIV: Preexposure Prophylaxis January 13, 2022 Recommendations made by the USPSTF are independent of the U.S. government. They…

69. Overdiagnosis in Prostate Cancer Screening Decision Models: A Contextual Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/KT7vaWK_JSDNNvEmUAjN8d
    May 01, 2018 - work of Zelen and Feinleib,7 which underpins the current modeling work on prostate cancer screening described … As we described earlier, the frequency of overdiagnosis can be expressed using one of three denominators … We do not formally critically appraise models but instead we identified and described the most important … On the basis of the classification scheme described by the International Society for Pharmacoeconomics … (p. 110) Davidov and Zelen16 applied the basic analytic modeling approach described by Zelen and

70. Screening Women for Intimate Partner Violence: A Systematic Review to Update teh 2004 USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/MjwZ4vRLZDVUSnfMA6SrDo
    June 01, 2012 - 40–42, 44, 46–50, 53), selected (that is, not randomly assigned or not consecutive) or inadequately described … ** The sampling method was not random or consecutive or not described. †† The reference standard was … Taft et al, 2011 (60) (Taft et al, 2009 [61] protocol and methods described) Mentor support vs. usual … high or differential. § Intention-to-treat analysis was not used. � The randomization method was not described … follow-up (55, 56), lack of intention-to-treat or unclear analyses (55, 56, 58), and inadequately described

71. Archived: Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit: Carotid Artery Stenosis: Screening, December 2007 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/update-on-the-methods-of-the-us-preventive-services-task-force-estimating-certainty-and-magnitude-of-net-bene%EF%AC%81t/carotid-artery-stenosis-screening-december-2007
    December 15, 2007 - and recommendation development. 4 At that time, the Task Force's overall assessment of evidence was described … will be determined by considering all 6 questions in Table 2 ; the judgment about certainty will be described

72. Archived: Final Evidence Summary: Dental Caries in Preschool Children: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary19/dental-caries-in-preschool-children-screening-2004
    April 15, 2004 - The single available study described an ineffective intervention. … Sweden, ~0.2 ppm 2-3 wk (705) 0.5 mg   F&V drops V drops Not described … 3 + y: 1.0 mg   F&V chews 0-3 y: V drops 3+ y: V chews Not described … 3 + y: 0.5   F drops None Children grouped by school, school assignment not described … drops E 2 : 0.25 mg   F chews None Random, method of randomization not described

73. Overdiagnosis in Prostate Cancer Screening Decision Models: A Contextual Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/Home/GetFile/1/16812/prostate-models-overdiagnosis/pdf
    May 01, 2018 - work of Zelen and Feinleib,7 which underpins the current modeling work on prostate cancer screening described … As we described earlier, the frequency of overdiagnosis can be expressed using one of three denominators … We do not formally critically appraise models but instead we identified and described the most important … On the basis of the classification scheme described by the International Society for Pharmacoeconomics … (p. 110) Davidov and Zelen16 applied the basic analytic modeling approach described by Zelen and

74. Evidence Summary: Intimate Partner Violence and Caregiver Abuse of Older or Vulnerable Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening
    June 24, 2025 - the Supplement). 42 Benefit of Interventions Among Nonpregnant Populations Six RCTs (n = 5712, described … Some existing studies have described the development of screening tools for use among transgender populations … was made to the hospital social worker or community specialist. c Estimate based on a questionnaire described … physicians were mailed a survey regarding participant and screening for fear of partner. g Usual care described … Unclear fidelity to intervention Insufficient New parents in a committed relationship (couples, described

75. Archived: Final Evidence Summary: Speech and Language Delay in Preschool Children: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary47/speech-and-language-delay-in-preschool-children-screening-2006
    February 15, 2006 - The performance characteristics of evaluation techniques that take ≤ 10 minutes to administer were described … Several types of speech and language delay and disorders have been described, 8 although terminology … Search terms were determined by investigators and a research librarian and are described elsewhere. 33 … be administered in a primary care setting by nonspecialists are most relevant to screening and are described … included speech and language measures as well as other functional and health outcomes as previously described

76. Draft Research Plan: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/brca-related-cancer-risk-assessment-genetic-counseling-testing
    January 18, 2024 - . ‡ Pretest genetic counseling, scope of services, and appropriate providers are described in the Research

77. Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/4y3P9DxovKMEjNmVd2mrPp
    December 01, 2007 - At that time, the Task Force’s overall assessment of evidence was described as good, fair, or poor. … will be determined by considering all 6 questions in Table 2; the judgment about certainty will be described

78. Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/benefit.pdf
    December 01, 2007 - At that time, the Task Force’s overall assessment of evidence was described as good, fair, or poor. … will be determined by considering all 6 questions in Table 2; the judgment about certainty will be described

79. Behavioral Interventions and Counseling to Prevent Child Abuse and Neglect: A Systematic Review to Update the USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/SUHq3jffCaucDobFXKewQ_
    February 01, 2013 - . † Analysis was not an intention-to-treat analysis or was not described. ‡ Randomized groups were not … similar at baseline or follow-up. § Inclusion/exclusion criteria were inadequate or not described. � … Randomization method was inadequate or not described. ¶ Blinding was inadequate or not described. ** … telephone – – – EC – – – – – – – Marital or family problems – – – EC – – – – – – – Criteria not further described … Al- though not described in the publication, during the SEEK trial, investigators maintained regular

80. Procedure Manual Appendix V. Work Plan/Research Plan Template | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-v-work-planresearch-plan-template
    July 01, 2017 - Procedure Manual Appendix V. Work Plan/Research Plan Template Share to Facebook Share to X Share to WhatsApp Share to Email Print For each topic, a preliminary draft of the work plan following this template is circulated prior to the first to…